• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Siemens gets nod for CT calcium scoring

Article

Siemens Medical Systems has received 510(k) clearance for a calcium scoring software package for cardiac CT studies. The software is designed to help physicians determine a patient’s risk of future cardiac problems by analyzing the amount of calcium

Siemens Medical Systems has received 510(k) clearance for a calcium scoring software package for cardiac CT studies. The software is designed to help physicians determine a patient’s risk of future cardiac problems by analyzing the amount of calcium in the coronary arteries.

The software is included on Siemens’ 3-D Virtuoso postprocessing workstation, and works with data collected by the company’s SubSecond Cardio CT scanning package (SCAN 4/29/99). The calcium scoring option enables radiologists to mark a region of interest and receive a calcium score for that area, using either Agatston or volume scores to measure the degree of calcification. The software also automatically creates reports for referring physicians, according to the company.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.